Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study.

ABSTRACT:

Background

Hyperbaric oxygen therapy (HBOT) has several hemodynamic effects including increases in afterload (due to vasoconstriction) and decreases in cardiac output. This, along with rare reports of pulmonary edema during emergency treatment, has led providers to consider HBOT relatively contraindicated in patients with reduced left ventricular ejection fraction (LVEF). However, there is limited evidence regarding the safety of elective HBOT in patients with heart failure (HF), and no existing reports of complications among patients with HF and preserved LVEF. We aimed to retrospectively review patients with preexisting diagnoses of HF who underwent elective HBOT, to analyze HBOT-related acute HF complications.

Methods

Research Ethics Board approvals were received to retro

SUBMITTER: Schiavo S 

PROVIDER: S-EPMC10852233 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature